Varaico: Literature-Extracted Genetic Variants

Gene:ERBB2
Variant:p.L33R
Back to variants list

ERBB2

NM_004448.4:p.L33R

Associated Papers

Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers.

Wilding B et al.

Cancer Discovery, 2025

39248702 (PubMed )
Supplement: cd-24-0306_supplementary_data_table_2_suppst2.xlsx › PRISM

Multiplex single-cell chemical genomics reveals the kinase dependence of the response to targeted therapy.

McFaline-Figueroa JL et al.

Cell Genomics, 2024

Cdk4 and Cdk6 Couple the Cell-Cycle Machinery to Cell Growth via mTORC1.

Romero-Pozuelo J et al.

Cell Reports, 2020

Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.

von Achenbach C et al.

Journal of Neurochemistry, 2018

Mutational profiling of kinases in glioblastoma.

Bleeker FE et al.

Bmc Cancer, 2014

Abstracts from the Third International Meeting of ISEV 2014 Rotterdam, The Netherlands, April 30(th) - May 3(rd), 2014.

Unknown Author

Journal of Extracellular Vesicles, 2014

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."